Skip to main content
SWOG logo

User account menu

  • Log in

Main navigation

  • About
    • History & Impact
    • Mission & Values
    • Leadership
    • Support SWOG
    • Join SWOG
    • Policies & Procedures
    • Careers
    • Contact Us
  • The SWOG Network
    • How We Work
    • Our Staff
    • Our Advocates
    • Our Partners
  • News & Events
    • News
    • SWOG Meetings
    • For Press
  • Clinical Trials
    • Biospecimen Submission
    • Biospecimen Access
    • Data Requests
    • Clinical Trials Search
    • Clinical Research Resources
    • Frequently Asked Questions
    • Publications
    • Institutions
    • Quality Assurance & Audits
    • Serious Adverse Events
    • Training Resources
    • CRA Workbench
    • Protocol Workbench
  • For Patients
    • Patient & Advocate Voices
    • Trials Open to Patients
    • About SWOG Cancer Trials
    • Joining a Trial

Breadcrumb

  1. SWOG
  2. News & Events
  3. News
  4. News

News

SIGN UP FOR EMAIL UPDATES
Dr. Priyanka Sharma
Press Release
Mar 19, 2018

New Findings on Triple Negative Breast Cancer

HRD-Positive Breast Cancer Patients Fare Better With Adjuvant AC Chemotherapy
The Front Line
The Front Line
Mar 16, 2018

Special Honors for Very Special SWOG Members

The Front Line
The Front Line
Mar 9, 2018

Deputy Chair Switch Coming in 2019

The Front Line
The Front Line
Mar 2, 2018

Color Our San Francisco Meeting Silver

The Front Line
The Front Line
Feb 23, 2018

SWOG Scores Rare Success with DART

Press Release DART Trial
Press Release
Feb 22, 2018

DART Trial Shows Early Enrollment Success

The Front Line
The Front Line
Feb 16, 2018

New Leadership for Quality, International

The Front Line
The Front Line
Feb 9, 2018

SWOG's Facebook Group Gets an Upgrade

Spring 2018 Group Meeting
Feb 6, 2018

Registration Is Open for Spring Meeting

  • Previous page ‹
  • First page 1
  • …
  • Page48
  • Current page49
  • Page50
  • …
  • Last page 62
  • Next page ›
SWOG logo

Footer: Social Links

  • LinkedIn
  • Twitter
  • YouTube
Copyright © 2025

Footer

  • Disclaimer